Candida sepsisB37.7

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Candidosis disseminated; Disseminated Candidosis

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Septic seeding of Candida albicans or other Candida species (especially in immunosuppression), mostly after candidoses of internal organs (lung, heart, intestine, CNS).

EtiopathogenesisThis section has been translated automatically.

Haematogenic spread of the pathogens.

LocalizationThis section has been translated automatically.

Generalized to trunk, face, extremities.

Clinical featuresThis section has been translated automatically.

Exanthema with 2-5 mm large reddish papules and pustules, possibly with purpura, fever, reduced general condition, vomiting, diarrhoea, weight loss.

DiagnosisThis section has been translated automatically.

Blood culture.

TherapyThis section has been translated automatically.

  • Amphotericin B (e.g. Amphotericin B Bristol-Myers-Squibb) i.v. in combination with Flucytosin (e.g. Ancotil) i.v. Amphotericin B: day 1: 0.1 mg/kg bw, day 2: 0.2 mg/kg bw, day 3: 0.3 mg/kg bw then 0.3 (-1.0) mg/kg bw/day i.v., Flucytosin 150 mg/kg bw in 4 ED.
  • Alternatively: Liposomal amphotericin B (e.g. AmBisome) initial 1 mg/kg bw i.v.; if required, stepwise increase to 3 mg/kg bw i.v. or Fluconazole (e.g. Diflucan) i.v. 2 times/day 200 mg.
  • In case of failure of all above mentioned therapies:
    • Attempt with caspofungin (e.g. Cancidas): initial 70 mg/day i.v. up to and including 7 days after the symptoms have subsided.
    • Alternatively voriconazole: 2 times/day (every 12 hours) 6 mg/kg bw. Maintenance dose from day 2: 2 times/day 4 mg/kg bw i.v. up to and including 7 days after remission.
    • Alternatively posaconazole: 2 times/day 400 mg (10 ml) p.o. (daily dose 800 mg) or 4 times/day 200 mg (5 ml) p.o. The duration of therapy depends on the severity of the underlying disease, recovery from immunosuppression and clinical response.
    • Alternatively, anidulafungin: Initial 200 mg i.v. as single dose. Subsequently, 100 mg i.v. once/day according to the clinical response.

Progression/forecastThis section has been translated automatically.

Awkward.

Authors

Last updated on: 29.10.2020